The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity

Journal of Bone and Joint Surgery

Volumn 91, Issue 6, 2009, Pages 1459-1470

  Han, Bo ^a   Woodell May, Jennifer ^b   Ponticiello, Michael ^c   Yang, Zhi ^a   Nimni, Marcel ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Biomet Incorporated   (United States)

^c Interpore Cross International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; THROMBIN; TRANSFORMING GROWTH FACTOR BETA1; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEMINERALIZATION; BONE DEVELOPMENT; BONE MARROW CELL; BONE MATRIX; CELL COUNT; CELLULAR DISTRIBUTION; CHONDROGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SYNTHESIS; HUMAN; IN VITRO STUDY; INFLAMMATORY CELL; MOUSE; MYOBLAST; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; STROMA CELL; THROMBOCYTE RICH PLASMA; ADULT; ANIMAL; BLOOD; BONE DENSITY; CELL CULTURE; CELL PROLIFERATION; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMPLANT; MALE; METABOLISM; MICROPHOTOGRAPHY; NUDE MOUSE; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION;

ADULT; ANIMALS; BONE DENSITY; BONE MATRIX; CELL PROLIFERATION; CELLS, CULTURED; CHONDROGENESIS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMPLANTS, EXPERIMENTAL; MALE; MICE; MICE, NUDE; OSTEOGENESIS; PHOTOMICROGRAPHY; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; SENSITIVITY AND SPECIFICITY; THROMBIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67649888046     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.H.00246     Document Type: Article

References (50)

1. Pietrzak WS, Woodell-May J, McDonald N. Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix. J Craniofac Surg. 2006;17:84-90. (Pubitemid 44383852)
2. Reddi AH. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng. 2000;6:351-359
3. Mehta S, Watson JT. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma. 2008;22:432-438
4. El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke TE. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol. 2007;78:661-669
5. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004;114:1502-1508 (Pubitemid 40361959)
6. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res. 2005;845:434-439 (Pubitemid 43827875)
7. van den Dolder J, Mooren R, Vloon AP, Stoelinga PJ, Jansen JA. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng. 2006;12:3067-3073 (Pubitemid 44846412)
8. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638-646
9. Aghaloo TL, Moy PK, Freymiller EG. Evaluation of platelet-rich plasma in combination with anorganic bovine bone in the rabbit cranium: a pilot study. Int J Oral Maxillofac Implants. 2004;19:59-65.
10. Jenis LG, Banco RJ, Kwon B. A prospective study of Autologous Growth Factors (AGF) in lumbar interbody fusion. Spine J. 2006;6:14-20. (Pubitemid 43079169)
11. Lucarelli E, Fini M, Beccheroni A, Giavaresi G, Di Bella C, Aldini NN, Guzzardella G, Martini L, Cenacchi A, Di Maggio N, Sangiorgi L, Fornasari PM, Mercuri M, Giardino R, Donati D. Stromal stem cells and platelet-rich plasma improve bone allograft integration. Clin Orthop Relat Res. 2005;435:62-68 (Pubitemid 40798647)
12. Aghaloo TL, Moy PK, Freymiller EG. Investigation of platelet-rich plasma in rabbit cranial defects: a pilot study. J Oral Maxillofac Surg. 2002;60:1176-1181
13. Froum SJ, Wallace SS, Tarnow DP, Cho SC. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent. 2002;22:45-53.
14. Ranly DM, Lohmann CH, Andreacchio D, Boyan BD, Schwartz Z. Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg Am. 2007;89:139-147 (Pubitemid 46059153)
15. Weiner BK, Walker M. Efficacy of autologous growth factors in lumbar intertransverse fusions. Spine. 2003;28:1968-1971 (Pubitemid 37082662)
16. Berghoff WJ, Pietrzak WS, Rhodes RD. Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics. 2006;29:590-598 (Pubitemid 44122629)
17. Everts PA, Knape JT, Weibrich G, Schönberger JP, Hoffmann J, Overdevest EP, Box HA, van Zundert A. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol. 2006;38:174-187
18. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;31:1774-1778 (Pubitemid 44735517)
19. Woodell-May JE, Ridderman DN, Swift MJ, Higgins J. Producing accurate platelet counts for platelet rich plasma: validation of a hematology analyzer and preparation techniques for counting. J Craniofac Surg. 2005;16:749-759 (Pubitemid 41428918)
20. Khalil N. TGF-beta: from latent to active. Microbes Infect. 1999;1:1255-1263
21. Han B, Hall FL, Nimni ME. Refolding of a recombinant collagen-targeted TGF-beta2 fusion protein expressed in Escherichia coli. Protein Expr Purif. 1997;11:169-178 (Pubitemid 27498905)
22. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem. 1994;216:276-284 (Pubitemid 24076008)
23. Hall FL, Han B, Kundu RK, Yee A, Nimni ME, Gordon EM. Phenotypic differentiation of TGF-beta1-responsive pluripotent premesenchymal prehematopoietic progenitor (P4 stem) cells from murine bone marrow. J Hematother Stem Cell Res. 2001;10:261-271 (Pubitemid 32423550)
24. Han B, Tang B, Nimni ME. Quantitative and sensitive in vitro assay for osteoinductive activity of demineralized bone matrix. J Orthop Res. 2003;21:648-654 (Pubitemid 36763488)
25. Nishimoto SK, Chang CH, Gendler E, Stryker WF, Nimni ME. The effect of aging on bone formation in rats: biochemical and histological evidence for decreased bone formation capacity. Calcif Tissue Int. 1985;37:617-624 (Pubitemid 16197171)
26. Reddi AH. Cell biology and biochemistry of endochondral bone development. Coll Relat Res. 1981;1:209-226
27. Urist MR, Hay PH, Dubuc F, Buring K. Osteogenetic competence. Clin Orthop Relat Res. 1969;64:194-220.
28. Urist MR. The search for and discovery of bone morphogenetic proteins (BMP). In: Urist MR, O'Connor BT, Burwell RG, editors. Bone grafts, derivatives and substitutes. London: Butterworth-Heinemann; 1994. p 315-362
29. Nikolidakis D, van den Dolder J, Wolke JG, Stoelinga PJ, Jansen JA. The effect of platelet-rich plasma on the bone healing around calcium phosphate-coated and non-coated oral implants in trabecular bone. Tissue Eng. 2006;12:2555-2563 (Pubitemid 46141278)
30. Zechner W, Tangl S, Tepper G, Fürst G, Bernhart T, Haas R, Mailath G, Watzek G. Influence of platelet-rich plasma on osseous healing of dental implants: a histologic and histomorphometric study in minipigs. Int J Oral Maxillofac Implants. 2003;18:15-22. (Pubitemid 37140448)
31. Barrow CR, Pomeroy GC. Enhancement of syndesmotic fusion rates in total ankle arthroplasty with the use of autologous platelet concentrate. Foot Ankle Int. 2005;26:458-461
32. Bibbo C, Bono CM, Lin SS. Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients. J Surg Orthop Adv. 2005;14:17-22.
33. Roussy Y, Bertrand Duchesne MP, Gagnon G. Activation of human platele-trich plasmas: effect on growth factors release, cell division and in vivo bone formation. Clin Oral Implants Res. 2007;18:639-648
34. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials. 2003;24:3095-3100 (Pubitemid 36944940)
35. Semple E, Madsen T, Semple JW. Quality of thrombin produced from the patient's own plasma using the TPD, a new Thrombin-processing Device. J Extra Corpor Technol. 2005;37:196-200. (Pubitemid 40967333)
36. Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fischer MB, Watzek G. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets. 2004;15:29-35. (Pubitemid 38283218)
37. Choi BH, Zhu SJ, Kim BY, Huh JY, Lee SH, Jung JH. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg. 2005;34:420-424
38. Ibbotson KJ, Orcutt CM, Anglin AM, D'Souza SM. Effects of transforming growth factors beta 1 and beta 2 on a mouse clonal, osteoblastlike cell line MC3T3-E1. J Bone Miner Res. 1989;4:37-45.
39. Dorion RP, Hamati HF, Landis B, Frey C, Heydt D, Carey D. Risk and clinical significance of developing antibodies induced by topical thrombin preparations. Arch Pathol Lab Med. 1998;122:887-894 (Pubitemid 28485270)
40. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg. 2001;233:88-96.
41. Rothenberg DM, Moy JN. Anaphylactic reaction to topical bovine thrombin. Anesthesiology. 1993;78:779-782
42. Tadokoro K, Ohtoshi T, Takafuji S, Nakajima K, Suzuki S, Yamamoto K, Ito K, Miyamoto T, Muranaka M. Topical thrombin-induced IgE-mediated anaphylaxis: RAST analysis and skin test studies. J Allergy Clin Immunol. 1991;88:620-629
43. Wai Y, Tsui V, Peng Z, Richardson R, Oreopoulos D, Tarlo SM. Anaphylaxis from topical bovine thrombin (Thrombostat) during haemodialysis and evaluation of sensitization among a dialysis population. Clin Exp Allergy. 2003;33:1730-1734 (Pubitemid 38005395)
44. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2003;91:4-15. (Pubitemid 38111215)
45. Karp JM, Tanaka TS, Zohar R, Sodek J, Shoichet MS, Davies JE, Stanford WL. Thrombin mediated migration of osteogenic cells. Bone. 2005;37:337-348 (Pubitemid 41160492)
46. Tarzami ST, Wang G, Li W, Green L, Singh JP. Thrombin and PAR-1 stimulate differentiation of bone marrow-derived endothelial progenitor cells. J Thromb Haemost. 2006;4:656-663
47. Pagel CN, Sivagurunathan S, Loh LH, Tudor EM, Pike RN, Mackie EJ. Functional responses of bone cells to thrombin. Biol Chem. 2006;387:1037-1041 (Pubitemid 44200497)
48. Andrews RK, Berndt MC. Platelet physiology and thrombosis. Thromb Res. 2004;114:447-453
49. Ranly DM, McMillan J, Keller T, Lohmann CH, Meunch T, Cochran DL, Schwartz Z, Boyan BD. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am. 2005;87:2052-2064 (Pubitemid 41279137)
50. Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone. 2004;34:665-671 (Pubitemid 38393802)